logo-loader
viewIXICO PLC

IXICO to present scientific poster on enhancing imaging analysis accuracy for Huntington's Disease

The poster presentation will be seen at the CHDI Foundation 15th Annual 2020 Huntington's Disease Therapeutics Conference held from 24-27 February, 2020 in Palm Springs, California, USA

Brain scan
The presentation is entitled ‘Fully automatic AI segmentation of subcortical regions: comparison of ATLAS and deep-learning-based approaches’

IXICO PLC (LON:IXI), the AI data analytics company delivering insights in neuroscience, announced that it is scheduled to present a scientific poster on enhancing imaging analysis accuracy for Huntington's Disease (HD) by comparing two types of Artificial Intelligence (AI) techniques.

The group said the presentation will be seen at the CHDI Foundation 15th Annual 2020 Huntington's Disease Therapeutics Conference held from 24-27 February, 2020 in Palm Springs, California, USA.

READ: IXICO joins forces with Alzheimer's disease neuroimaging initiative

It noted that the poster presentation, entitled ‘Fully automatic AI segmentation of subcortical regions: comparison of ATLAS and deep-learning-based approaches’, compares and contrasts two AI approaches for anatomical segmentation - the first, an established atlas-based manifold learning technique, IXICO's proprietary LEAP technology; the second, a deep-learning model based on a 3D convolutional neural network (CNN).

Dr Robin Wolz, senior vice president, Science & Innovation at IXICO commented: "Huntington's Disease continues to be a focus for IXICO in its efforts to provide pioneering technologies to support the advancement of effective treatments for rare neurological diseases.

“Our research in imaging analytics will provide an insight into the best methods for monitoring both the progression of the disease as well as the potential effect of interventional treatments."

IXICO said it will be attending/presenting at a number of other upcoming conferences:

  • Neurodegenerative Drug Development Summit: 25-27 February 2020, Hyatt Regency Boston, Boston, USA
  • ARCA Global Conference: 2-3 March 2020, Sheraton Denver Downtown, Denver, USA
  • The Wearable Technology Show: 10-11 March 2020, The Business Design Centre, London, UK
  • ADPD Focus Meeting: 2-5 April 2020, Austria Center, Vienna, Austria
  • SCA Global Conference: 6-7 April 2020: German Center for Neurodegenerative Diseases, Bonn, Germany
  • BioTrinity 2020: 28-29 April 2020, venues, 155 Bishopsgate, London, UK
  • 17th Annual Anglonordic Life Science Conference: 23-24 June 2020, County Hall, London, UK

Quick facts: IXICO PLC

Price: 69 GBX

AIM:IXI
Market: AIM
Market Cap: £32.49 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of IXICO PLC named herein, including the promotion by the Company of IXICO PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

IXICO PLC 'scaling quickly' as it reports 33% growth in first half revenue

IXICO PLC's (LON:IXI) Giulio Cerroni discusses with Proactive London's Andrew Scott the brain imaging and neuroscience data specialist's first half results. For the six months ended 31 March, IXICO reported earnings of £700,000, up from £100,000 a year ago, while revenues surged 33% to...

1 week, 4 days ago

2 min read